Consistent with these results, it has been reported that Fas transcript is decreased in the active phase of MS patients (77), and Fas expression on the surface of CD4+ CCR5+ T cells, a T cell subset implicated in MS (78, 79), is decreased in MS patients compared to healthy donors (HD) (80). Here, CD4 is linked to myeloid sarcoma.